Clinical Trial Update: STAAR-1 Clinical Study [Phase 4]

View source ↗

Summary

Amgen reports the Phase 4 STAAR-1 trial in chronic kidney disease-related conditions has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• End-stage Renal Disease

Drugs mentioned

• darbepoetin alfa (darbepoetin alfa)

Snippet

Sponsor: Amgen | Conditions: Chronic Kidney Disease, Chronic Renal Insufficiency | Phase 4 | Status: COMPLETED